SCHEMBL7572236

SCHEMBL7572236

CCC1OC1(CCCCCCOCCC1=CC=CCC1=S)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7573935 0.83 ABCB11 (0.31)
SCHEMBL7572988 0.74 PTGES (0.35)
SCHEMBL8013770 0.70 ALDH1A1 (0.32)
SCHEMBL7570704 0.69 ALDH1A1 (0.41)
SCHEMBL7578532 0.69 LMNA (0.32)
SCHEMBL8016482 0.68 SLC1A3 (0.37)
SCHEMBL8017823 0.68 ABCB11 (0.32)
SCHEMBL8021086 0.67 L3MBTL1 (0.30)
SCHEMBL7577303 0.67 HDAC4 (0.30)
SCHEMBL7571141 0.67 ABCB11 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020198382-A1 Oxiran carboxylic acids for the treatment of diabetes HORST P.O. WOLF (DE) 2002-12-26 US disclosed
US-6013666-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION Jew, Sang Sup (KR) 2000-01-11 US disclosed
WO-1998000422-A1 OXIRANE CARBOXYLIC ACID DERIVATIVE AND ITS MANUFACTURING METHOD JEW SANG SUP (KR) 1998-01-08 WO disclosed